TheraRadar
← Back
Data updated: Mar 29, 2026

UNIQUE

CardiovascularInfectious DiseaseDermatology
Generics

UNIQUE is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Dermatology.

2004
Since
16
Drugs
-
Trials
165
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

VENLAFAXINE HYDROCHLORIDE 2026-01-30
Labeling
CETIRIZINE HYDROCHLORIDE ALLERGY 2026-01-30
Labeling
CLOMIPRAMINE HYDROCHLORIDE 2026-01-28
Labeling
AMITRIPTYLINE HYDROCHLORIDE 2026-01-09
Labeling
CARBAMAZEPINE 2026-01-05
Labeling
DICLOFENAC SODIUM 2025-12-31
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-12-17
Labeling
DICLOFENAC SODIUM 2025-11-05
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 43%
3 drugs
Infectious Disease 14%
1 drugs
Dermatology 14%
1 drugs
Immunology 14%
1 drugs
Neurology 14%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

PAI HOLDINGS PHARM big-pharma
Dermatology, Infectious Disease, Neurology, Cardiovascular, Immunology
Pfizer big-pharma
Infectious Disease, Dermatology, Immunology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Immunology
BAUSCH AND LOMB specialty
Cardiovascular, Infectious Disease, Dermatology, Immunology
Merck big-pharma
Infectious Disease, Cardiovascular, Immunology